483 Alexion Pharmaceuticals Sep 2014

483 Alexion Pharmaceuticals Sep 2014

Maya Davis FDA$119.00 - Available Now

FDA investigators audited the Alexion Pharmaceuticals - New Haven, CT, United States facility and issued 2 inspectional observations (via FDA 483) on 26 Sep 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 26 Sep 2014
  • Location: New Haven, United States
  • FEI: 3006031727
Add To Cart